PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms
Cancers · 25.07.2023 · 15 (15) · 3759
DOI: 10.3390/cancers15153759 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.07.2023. Verfasst von Sinan Akay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Sinonasal cancers are uncommon malignancies with a generally unfavorable prognosis, often presenting at an advanced stage. Their high rate of recurrence supports close imaging surveillance and the utilization of functional imaging techniques. Whole-body 18F-FDG PET/CT has very high sensitivity for the diagnosis of sinonasal malignancies and can also be used as a “metabolic biopsy” in the characterization of some of the more common subgroups of these tumors, though due to overlap in uptake, histological confirmation is still needed. For certain tumor types, radiotracers, such as 11C-choline, and radiolabeled somatostatin analogs, including 68Ga-DOTATATE/DOTATOC, have proven useful in treatment planning and surveillance. Although serial scans for posttreatment surveillance allow the detection of subclinical lesions, the optimal schedule and efficacy in terms of survival are yet to be determined. Pitfalls of 18F-FDG, such as post-surgical and post-radiotherapy crusting and inflammation, may cause false-positive hypermetabolism in the absence of relapse.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nuclear Medicine, Department of Radiology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
- Department of Radiology, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA 90030, USA.
ORCID-Profile: Assim Saad Eddin, Aiah Alatoum, Michael M Graham
Förderung
- NCI NIH HHS
Zitieren
APA
Akay, S., Pollard, J. H., Saad Eddin, A., Alatoum, A., Kandemirli, S., Gholamrezanezhad, A., Menda, Y., Graham, M. M., & Shariftabrizi, A. (2023). PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms. Cancers, 15(15), 3759. https://doi.org/10.3390/cancers15153759
Vancouver
Akay S, Pollard JH, Saad Eddin A, Alatoum A, Kandemirli S, Gholamrezanezhad A, et al. PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms. Cancers. 2023;15(15):3759. doi:10.3390/cancers15153759
BibTeX
@article{Akay2023,
author = {Akay, Sinan and Pollard, Janet H and Saad Eddin, Assim and Alatoum, Aiah and Kandemirli, Sedat and Gholamrezanezhad, Ali and Menda, Yusuf and Graham, Michael M and Shariftabrizi, Ahmad},
title = {PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms},
journal = {Cancers},
year = {2023},
volume = {15},
number = {15},
pages = {3759},
doi = {10.3390/cancers15153759}
}
EUVIMED